BACKGROUND: Interactions of endothelial progenitor cells (EPCs) with vascular and blood cells contribute to vascular homeostasis. Although platelets promote the homing of EPCs to sites of vascular injury and their differentiation into endothelial cells, the functional consequences of such interactions on platelets remain unknown. Herein, we addressed the interactions between EPCs and platelets and their impact on platelet function and thrombus formation. METHODS AND RESULTS: Cultured on fibronectin in conditioned media, human peripheral blood mononuclear cells differentiated, within 10 days of culture, into EPCs, which uptake acetylated low-density lipoprotein, bind ulex-lectin, lack monocyte/leukocyte markers (CD14, P-selectin glycoprotein ligand-1, L-selectin), express progenitor/endothelial markers (CD34, vascular endothelial growth factor receptor-2, von Willebrand factor, and vascular endothelial cadherin), and proliferate in culture. These EPCs bound activated platelets via CD62P and inhibited its translocation, glycoprotein IIb/IIIa activation, aggregation, and adhesion to collagen, mainly via prostacyclin secretion. Indeed, this was associated with upregulation of cyclooxygenase-2 and inducible nitric oxide synthase. However, the effects on platelets in vitro were reversed by cyclooxygenase and cyclooxygenase-2 inhibition but not by nitric oxide or inducible nitric oxide synthase inhibition. Moreover, in a ferric chloride-induced murine arterial thrombosis model, injection of EPCs led to their incorporation into sites of injury and impaired thrombus formation, leading to an incomplete occlusion with 50% residual flow. CONCLUSIONS: Peripheral blood mononuclear cell-derived EPCs bind platelets via CD62P and inhibit platelet activation, aggregation, adhesion to collagen, and thrombus formation, predominantly via upregulation of cyclooxygenase-2 and secretion of prostacyclin. These findings add new insights into the biology of EPCs and define their potential roles in regulating platelet function and thrombosis.
BACKGROUND: Interactions of endothelial progenitor cells (EPCs) with vascular and blood cells contribute to vascular homeostasis. Although platelets promote the homing of EPCs to sites of vascular injury and their differentiation into endothelial cells, the functional consequences of such interactions on platelets remain unknown. Herein, we addressed the interactions between EPCs and platelets and their impact on platelet function and thrombus formation. METHODS AND RESULTS: Cultured on fibronectin in conditioned media, human peripheral blood mononuclear cells differentiated, within 10 days of culture, into EPCs, which uptake acetylated low-density lipoprotein, bind ulex-lectin, lack monocyte/leukocyte markers (CD14, P-selectin glycoprotein ligand-1, L-selectin), express progenitor/endothelial markers (CD34, vascular endothelial growth factor receptor-2, von Willebrand factor, and vascular endothelial cadherin), and proliferate in culture. These EPCs bound activated platelets via CD62P and inhibited its translocation, glycoprotein IIb/IIIa activation, aggregation, and adhesion to collagen, mainly via prostacyclin secretion. Indeed, this was associated with upregulation of cyclooxygenase-2 and inducible nitric oxide synthase. However, the effects on platelets in vitro were reversed by cyclooxygenase and cyclooxygenase-2 inhibition but not by nitric oxide or inducible nitric oxide synthase inhibition. Moreover, in a ferric chloride-induced murine arterial thrombosis model, injection of EPCs led to their incorporation into sites of injury and impaired thrombus formation, leading to an incomplete occlusion with 50% residual flow. CONCLUSIONS: Peripheral blood mononuclear cell-derived EPCs bind platelets via CD62P and inhibit platelet activation, aggregation, adhesion to collagen, and thrombus formation, predominantly via upregulation of cyclooxygenase-2 and secretion of prostacyclin. These findings add new insights into the biology of EPCs and define their potential roles in regulating platelet function and thrombosis.
Authors: Harald Langer; Andreas Eberhard May; Karin Daub; Ulrich Heinzmann; Peter Lang; Michael Schumm; Dietmar Vestweber; Steffen Massberg; Tanja Schönberger; Iris Pfisterer; Antonis K Hatzopoulos; Meinrad Gawaz Journal: Circ Res Date: 2005-12-22 Impact factor: 17.367
Authors: H C de Boer; C Verseyden; L H Ulfman; J J Zwaginga; I Bot; E A Biessen; T J Rabelink; A J van Zonneveld Journal: Arterioscler Thromb Vasc Biol Date: 2006-04-20 Impact factor: 8.311
Authors: Mervin C Yoder; Laura E Mead; Daniel Prater; Theresa R Krier; Karim N Mroueh; Fang Li; Rachel Krasich; Constance J Temm; Josef T Prchal; David A Ingram Journal: Blood Date: 2006-10-19 Impact factor: 22.113
Authors: Eli I Lev; Zeev Estrov; Khatira Aboulfatova; David Harris; Juan F Granada; Carlos Alviar; Neal S Kleiman; Jing-fei Dong Journal: Thromb Haemost Date: 2006-10 Impact factor: 5.249
Authors: Karin Daub; Harald Langer; Peter Seizer; Konstantinos Stellos; Andreas E May; Pankaj Goyal; Boris Bigalke; Tanja Schönberger; Tobias Geisler; Dorothea Siegel-Axel; Robert A J Oostendorp; Stephan Lindemann; Meinrad Gawaz Journal: FASEB J Date: 2006-10-31 Impact factor: 5.191
Authors: Steffen Massberg; Ildiko Konrad; Katrin Schürzinger; Michael Lorenz; Simon Schneider; Dietlind Zohlnhoefer; Katharina Hoppe; Matthias Schiemann; Elisabeth Kennerknecht; Susanne Sauer; Christian Schulz; Sandra Kerstan; Martina Rudelius; Stefan Seidl; Falko Sorge; Harald Langer; Mario Peluso; Pankaj Goyal; Dietmar Vestweber; Nikla R Emambokus; Dirk H Busch; Jon Frampton; Meinrad Gawaz Journal: J Exp Med Date: 2006-04-17 Impact factor: 14.307
Authors: Thomas Ziebart; Anne Schnell; Christian Walter; Peer W Kämmerer; Andreas Pabst; Karl M Lehmann; Johanna Ziebart; Marc O Klein; Bilal Al-Nawas Journal: Clin Oral Investig Date: 2012-03-10 Impact factor: 3.573
Authors: Alexander U Ernst; Daniel T Bowers; Long-Hai Wang; Kaavian Shariati; Mitchell D Plesser; Natalie K Brown; Tigran Mehrabyan; Minglin Ma Journal: Adv Drug Deliv Rev Date: 2019-02-02 Impact factor: 15.470
Authors: John D Stroncek; Yujing Xue; Nabila Haque; Jeffrey H Lawson; William M Reichert Journal: Tissue Eng Part A Date: 2011-05-25 Impact factor: 3.845
Authors: Melissa A Brown; Lisheng Zhang; Vrad W Levering; Jiao-Hui Wu; Lisa L Satterwhite; Leigh Brian; Neil J Freedman; George A Truskey Journal: Arterioscler Thromb Vasc Biol Date: 2010-08-26 Impact factor: 8.311